Clinical, histological, and molecular risk factors for cancer recurrence in patients with stage II colon cancer - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue European Journal of Gastroenterology & Hepatology Année : 2016

Clinical, histological, and molecular risk factors for cancer recurrence in patients with stage II colon cancer

Thierry Lecomte

Résumé

Introduction The assessment of risk factors of cancer recurrence in patients with stage II colon cancer (CC) is crucial. Our aim was to study the clinical, histological, and molecular features associated with 3-year disease-free survival in a series of consecutive patients with stage II CC treated in three regional digestive oncology centers. Methods Clinical and histological data of all patients after curative surgery for stage II CC, treated from 2001 until 2009, were collected retrospectively. Histological samples were obtained and tested prospectively for microsatellite instability using fluorescent PCR amplification. Cox proportional hazards regression models were used to calculate P values, hazard ratios (HRs), and 95% confidence intervals (CIs). Results Among 195 patients studied, 22 (11%) had disease recurrence during the 3-year period following diagnosis. On multivariate analysis, only low number of lymph nodes (HR = 3.81, 95% CI: 1.19–12.19, P = 0.02) and T4 status (HR = 5.49, 95% CI: 1.06–28.43, P = 0.04) were associated significantly with an increased risk of relapse. Conclusion In this series of stage II CC patients, only T4 status and low number of lymph nodes were independent risk factors for poor 3-year disease-free survival, suggesting that patients with these features should be considered for adjuvant chemotherapy. Eur

Domaines

Cancer
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée
Loading...

Dates et versions

inserm-01405721 , version 1 (30-11-2016)

Identifiants

Citer

Yann Touchefeu, Marie Provost-Dewitte, Thierry Lecomte, Alain Morel, Isabelle Valo, et al.. Clinical, histological, and molecular risk factors for cancer recurrence in patients with stage II colon cancer. European Journal of Gastroenterology & Hepatology, 2016, 28, pp.1394 - 1399. ⟨10.1097/MEG.0000000000000725⟩. ⟨inserm-01405721⟩
106 Consultations
2 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More